A new generic formulation of pyridostigmine bromide — a muscle-strengthening medication sold under the brand name Mestinon — is now available for people with myasthenia gravis (MG) in the U.S. [read more in Myasthenia Gravis News]
Posts Categorized: blog
Read study results on patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations
Scientific Reports shares results from a study that looks at disease burden. Public domain digital conversations about MG were analyzed to describe mindsets and sentiments about the disease, its burden, and its treatments among men and women with MG and, more specifically, those treated with steroids and those receiving IVIg.
Ask An Expert – What you should know about the newest therapy options.
Our MG community took note of the recent news regarding the latest therapy options that aim to reduce the burden of hours-long treatment delivery with IVIG. For those who are responding well to this new treatment, it’s a game changer. But we recognize that many patients are interesting in learning more, so here are some… Read more »
Conquer MG is seeking new Board of Trustees
Conquer MG is seeking nominations for qualified individuals to serve on its Board of Trustees. This is an incredible group of people who care deeply about the well-being of those who experience or know someone with myasthenia gravis. Our role as board members is to help people with myasthenia gravis and their caregivers access information,… Read more »
Untold Stories: Life with Myasthenia Gravis – A podcast
From our partner, argenx is a new podcast, the “Untold Stories: Life with Myasthenia Gravis.” Take a listen to the first season that explores the real and untold stories of life with myasthenia gravis (MG), finding hope and community in each MG journey.
